Linked Life Data

19414678

Source:http://linkedlifedata.com/resource/pubmed/id/19414678

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2009-5-29
pubmed:abstractText
Currently, treatment recommendations for small-cell urothelial cancer (SCUC) are based on anecdotal case reports and small retrospective series. We now report results from the first phase II clinical trial developed exclusively for SCUC, to our knowledge.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2592-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19414678-Adult, pubmed-meshheading:19414678-Aged, pubmed-meshheading:19414678-Aged, 80 and over, pubmed-meshheading:19414678-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19414678-Brain Neoplasms, pubmed-meshheading:19414678-Carcinoma, Small Cell, pubmed-meshheading:19414678-Chemotherapy, Adjuvant, pubmed-meshheading:19414678-Cisplatin, pubmed-meshheading:19414678-Cystectomy, pubmed-meshheading:19414678-Disease-Free Survival, pubmed-meshheading:19414678-Doxorubicin, pubmed-meshheading:19414678-Etoposide, pubmed-meshheading:19414678-Female, pubmed-meshheading:19414678-Humans, pubmed-meshheading:19414678-Ifosfamide, pubmed-meshheading:19414678-Kaplan-Meier Estimate, pubmed-meshheading:19414678-Male, pubmed-meshheading:19414678-Middle Aged, pubmed-meshheading:19414678-Neoadjuvant Therapy, pubmed-meshheading:19414678-Neoplasm Staging, pubmed-meshheading:19414678-Prospective Studies, pubmed-meshheading:19414678-Time Factors, pubmed-meshheading:19414678-Treatment Outcome, pubmed-meshheading:19414678-Urinary Bladder Neoplasms, pubmed-meshheading:19414678-Urothelium
pubmed:year
2009
pubmed:articleTitle
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
pubmed:affiliation
Department of Genitourinary Medical Oncology, Urology, and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. asiefker@mdanderson.org
pubmed:publicationType
Journal Article, Clinical Trial, Phase II